PerpEquities

Equity · Healthcare

CVS Health Corporation (CVS) perpetual futures

CVS perpetual futures on 3 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade CVSUSDT.

CVS Health Corporation provides healthcare services through segments covering health care benefits, health services, pharmacy and consumer wellness, and corporate functions.

$80.64-12.5%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · BingX (CVS-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

3/3 live markets
Venues
3
Live markets
3/3
24h volume
$530.7K
Open interest
$325.1K
Best liquidity
$24.3K
BingX
Tightest spread
+59.5 bps
MEXC
Highest volume
$249.2K
BingX
Settlement mix
USDT · 3/3
Perp/spot vol.
0.00x
Spot volume $2.8B
OI / float
0.00%
Float $102.9B
Spot performance
1D-12.53%
5D-13.04%
1M-7.52%
6M-2.50%
YTD+0.76%
1Y+2.41%

Venue matrix

3 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeCVS-USDTTrading$80.64+37.2% APR
+0.034% every 8h		+101.7 bps$24.3K$249.2K$7.7KUSDT-
MEXCTradeCVS/USDTTrading$80.48+39.2% APR
+0.036% every 8h		+59.5 bps$4.4K$213.5K$209KUSDT20x
Gate.ioTradeCVS/USDTTrading$80.740.0% APR
0.000% every 8h		+192.9 bps$632.5$68K$108.4KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 3 venues absorb $10k

Too thin: MEXC

No fresh book data: BingX, Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

CVS
BingX · CVS-USDT$24.3K

Tightest spread

CVS
MEXC · CVS/USDT+59.5 bps

Highest volume

CVS
BingX · CVS-USDT$249.2K

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-11-04 · next report 2027-02-09 · Updated 59m ago
All financials →

Valuation & key figures

Market cap
$102.3B
Updated 59m ago
Revenue
$420.6B
Trailing 12 months
Revenue growth
+4%
Next fiscal year
Profit margin
+2.6%
P/E
9.2
Peer P/E 23.1
P/S
0.2
Peer P/E
23.1
Similar listed perps
Free cash flow
$15.6B
Trailing 12 months
Net income
$11.1B
Trailing 12 months
Revenue estimate
$417.7B
Next fiscal year
Earnings
2027-02-09
Revenue est. $107.2B · Updated 59m ago
Dividend
$0.665
2026-10-22
Revenue (TTM)$421B+6.7% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)3.6%+2.3 pp vs a year agoOperating income $15.1B
Net income (TTM)$11.1B+2,256.7% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$15.6B+147.4% vs a year agoCapex $3.14B
Diluted EPS (TTM)$8.59+2,160.5% vs a year agoSum of the last 4 quarters
Net cash-$60.4B+14.3% vs a year agoCash + short-term investments - debt
  • Last report (2026-11-04): revenue beat by 3.5%, EPS beat by 26.7%Revenue $108B vs $105B expected (+3.5%); EPS $2.09 vs $1.65 (+26.7%).
  • Revenue growth slowing: 5.4% year on yearQ3 '26 revenue $108B, against an average of 7.4% over the four quarters before.
  • Operating margin 3.6% (TTM), +2.3 pp on a year agoOperating income grew 206.4% while revenue grew 6.7%.
  • 24.3% of pre-tax profit is eaten by non-operating lossesPre-tax income $12.1B vs operating income $15.1B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Pharmacy Revenue$64.1B+7.6%61.1%
Premiums$34.6B+2.5%33.0%
Front Store Revenue$5.16B-0.5%4.9%
Product and Service, Other$1.04B+1.2%1.0%
Corporate And Other Segment–––
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 357 lines CVS Health Corp. reported to the SEC

Next catalyst

Catalysts

Earnings
2027-02-09
Revenue est. $107.2B · Updated 59m ago
Dividend
$0.665
2026-10-22

No unusual perp activity right now.

Reference data

Market context

Reference market

Closed
New York Stock Exchange
Regular hours
09:30 AM – 04:00 PM
Next holiday
Nov 26, 2026 · Thanksgiving Day

After-hours reference

Bid80.31
Ask81.81
Volume34,287,057

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20268.05$417.7B+4%17
FY 20278.53$429.8B+7%18
FY 20289.70$449.3B+12%13
FY 202910.84$474.6B+18%10
FY 203011.75$491.9B+22%5
Q1 20272.68$102.7B+2%6

Company events

6
2027-02-09EarningsActual - / Estimate 1.25-
2026-11-04Earnings · Before market openActual 2.09 / Estimate 1.65Beat
2026-10-22Dividend$0.665-
2026-08-05EarningsActual 2.58 / Estimate 1.85Beat
2026-07-23Dividend$0.665-
2026-05-06EarningsActual 2.57 / Estimate 2.18Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
HCA$102.5B1.357.5+8.6%2MRNA$103.2B46.3-32.4-141.4%23REGN$99B5.920.5+28.5%7ELV$95.4B0.518.7+2.5%2SYK$111.9B4.330.9+13.8%3MCK$124.6B0.327.4+1.1%2BMY$127.7B2.613.8+18.5%1MDT$134.3B3.625.7+13.9%9

Company data

Company intelligence

Updated: Nov 2, 2026, 02:51 PM UTC

Company profile

Sector
Healthcare
Industry
Medical - Healthcare Plans
Chief executive
J. David Joyner
Employees
259,500
IPO date
Feb 21, 1973
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei2.46
Piotroski scorei7/9
Overall ratingiB+
Owner earningsi$6.34B$4.94 per share
ESG risk ratingiBIndustry rank: 5 out of 15

Rating factors

Return on equityi
3
Return on assetsi
3
Debt to equityi
1
Price to earningsi
2
Price to booki
4

Company press releases

Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?PRNewsWireCVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVSBusiness WireAetna Provider Survey Shows Payer-Provider Trust Remains Strong; Providers say Reducing Fraud can Significantly Lower Health Care CostsPRNewsWireCVS Pharmacy expands fall assortment of collectibles, nostalgic favorites and seasonal exclusivesPRNewsWireMinuteClinic® opens three new retail medical clinics to serve Massachusetts patientsPRNewsWireCVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journeyPRNewsWire

Congressional disclosures

Senate

House

Market cap history
$115.16B-14.3%Aug 26 – Oct 26
$111.02B$122.74B$134.45BHigh: $134.45B · 2026-08-03Low: $111.02B · 2026-10-05Latest: $115.16B · 2026-10-30Aug 26Sep 26Oct 26
Latest: $115.16B · 2026-10-30High: $134.45B · 2026-08-03Low: $111.02B · 2026-10-05
Largest fund holders
FundWeightShares held
VTI0.15%40.6M
VOO0.17%33.6M
VCPA.S0.57%26.7M
IVV0.18%17.1M
1657.T0.14%17.1M
XSP.TO0.17%17M
XWD.TO0.13%17M
FXAIX0.17%15.8M
SPY0.17%15.6M
VSCA.S0.43%13.1M
VTV0.42%12.2M
VGHAX2.29%10.2M

Analyst track record

How the analysts covering CVS have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings131436
Analysts2333
Buy / hold / sell123 / 8 / 0350 / 86 / 0
Upgrades / downgrades / initiations1 / 0 / 011 / 6 / 6
Price targets hit / missed7 / 120 (6%)259 / 153 (63%)
Avg. return after a rating (TipRanks)-12.1%+10.7%
Best / worst call+7.5% / -28.3%+77.1% / -28.3%

After buy calls on this stock: median 21-day move +1.8% vs S&P 500 +0.7% (n = 363)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Stephen BaxterWells Fargo100% hit rate on this stock · 14 targets measuredBuytarget $123Nov 3, 2026
  2. Elizabeth Anderson CFAEvercore ISI91% hit rate on this stock · 23 targets measuredBuytarget $110Nov 4, 2026
  3. Andrew Mok CFABarclays89% hit rate on this stock · 9 targets measuredBuytarget $108Nov 4, 2026

Latest ratings

DateAnalystCallTarget
Nov 4, 2026Elizabeth Anderson CFAEvercore ISIBuyReiterated$110article ↗
Nov 4, 2026Elizabeth Anderson CFAEvercore ISIBuyReiterated$110article ↗
Nov 4, 2026Lance WilkesBernsteinBuyMaintained$112article ↗
Nov 4, 2026Erin WrightMorgan StanleyBuyMaintained$111article ↗
Nov 3, 2026Allen LutzBank of America SecuritiesBuyMaintained$110article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$70.00$80.00$90.00$100$110Dec 25 · Buy 20 · Hold 1 · Sell 0Dec 25Jan 26 · Buy 21 · Hold 1 · Sell 0Feb 26 · Buy 21 · Hold 2 · Sell 0Feb 26Mar 26 · Buy 20 · Hold 1 · Sell 0Apr 26 · Buy 19 · Hold 1 · Sell 0Apr 26May 26 · Buy 19 · Hold 1 · Sell 0Jun 26 · Buy 19 · Hold 1 · Sell 0Jun 26Jul 26 · Buy 19 · Hold 2 · Sell 0Aug 26 · Buy 20 · Hold 1 · Sell 0Aug 26Sep 26 · Buy 19 · Hold 1 · Sell 0Oct 26 · Buy 20 · Hold 1 · Sell 0Oct 26Nov 26 · Buy 20 · Hold 1 · Sell 0Dec 25 · avg. target $93.52Jan 26 · avg. target $93.32Feb 26 · avg. target $94.19Mar 26 · avg. target $95.74Apr 26 · avg. target $96.50May 26 · avg. target $102Jun 26 · avg. target $104Jul 26 · avg. target $109Aug 26 · avg. target $113Sep 26 · avg. target $113Oct 26 · avg. target $113Nov 26 · avg. target $113Dec 25 · month-end close $79.36Jan 26 · month-end close $74.52Feb 26 · month-end close $79.90Mar 26 · month-end close $71.82Apr 26 · month-end close $83.29May 26 · month-end close $90.98Jun 26 · month-end close $103Jul 26 · month-end close $104Aug 26 · month-end close $93.91Sep 26 · month-end close $85.69Oct 26 · month-end close $90.25Nov 26 · month-end close $90.25

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 5, 2026 · 131 ratings

Frequently asked questions

Where can I trade CVS perpetual futures?

CVS Health Corporation (CVS) perpetual futures trade on 3 crypto venues, including BingX, MEXC, Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade CVS around the clock?

Yes. Unlike the underlying stock, CVS perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on CVS perpetuals?

Right now the CVS perp funding rate is +37.2% annualized (venue median), ranging from 0.0% to +39.2% across 3 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the CVS perp price compare to the CVS Health Corporation stock?

The venue-median CVS perp mark is $80.6 versus a reference stock price of $80.6, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a CVS perpetual future?

A CVS perpetual is a derivative that tracks the price of CVS Health Corporation with no expiry date. It lets you take long or short exposure to CVS Health Corporation on crypto venues, around the clock.

What is CVSUSDT perpetual?

CVSUSDT is the symbol most crypto exchanges use for the CVS Health Corporation perpetual settled in USDT (Tether). It tracks the CVS share price through an index, trades 24/7 with leverage and never expires.

Other Healthcare perps

Also listed on BingX

Also listed on MEXC

Also listed on Gate.io

Embed this asset

CVS perpetuals · perpequities.comCVS perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/cvs-perp"><img src="https://perpequities.com/badge/cvs-perp.svg" width="240" height="64" alt="CVS perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Next step

Stay on top of CVS perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for CVS — one email every Sunday.

Watchlist and alerts

Price and funding alerts for CVS, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X